Discovery and Biochemical Characterization of PlyP56, PlyN74, and PlyTB40- Specific Endolysins.

Printer-friendly versionPrinter-friendly versionPDF versionPDF version
TitleDiscovery and Biochemical Characterization of PlyP56, PlyN74, and PlyTB40- Specific Endolysins.
Publication TypeJournal Article
Year of Publication2018
AuthorsEtobayeva, I, Linden, SB, Alem, F, Harb, L, Rizkalla, L, Mosier, PD, Johnson, AA, Temple, L, Hakami, RM, Nelson, DC
Date Published2018 05 21

Three bacteriophage-derived endolysins, designated PlyP56, PlyN74, and PlyTB40, were identified, cloned, purified, and characterized for their antimicrobial properties. Sequence alignment reveals these endolysins have an N-terminal enzymatically active domain (EAD) linked to a C-terminal cell wall binding domain (CBD). PlyP56 has a Peptidase_M15_4/VanY superfamily EAD with a conserved metal binding motif and displays biological dependence on divalent ions for activity. In contrast, PlyN74 and PlyTB40 have T7 lysozyme-type Amidase_2 and carboxypeptidase T-type Amidase_3 EADs, respectively, which are members of the MurNAc-LAA superfamily, but are not homologs and thus do not have a shared protein fold. All three endolysins contain similar SH3-family CBDs. Although minor host range differences were noted, all three endolysins show relatively broad antimicrobial activity against members of the group with the highest lytic activity against ATCC 4342. Characterization studies determined the optimal lytic activity for these enzymes was at physiological pH (pH 7.0⁻8.0), over a broad temperature range (4⁻55 °C), and at low concentrations of NaCl (<50 mM). Direct comparison of lytic activity shows the PlyP56 enzyme to be twice as effective at lysing the cell wall peptidoglycan as PlyN74 or PlyTB40, suggesting PlyP56 is a good candidate for further antimicrobial development as well as bioengineering studies.

Alternate JournalViruses
PubMed ID29883383
PubMed Central IDPMC5977269